nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Zolmitriptan—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Zolmitriptan—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Zolmitriptan—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Zolmitriptan—Asthenia—Teniposide—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Zolmitriptan—Melaena—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Zolmitriptan—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Zolmitriptan—Malaise—Bleomycin—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Zolmitriptan—Pruritus—Teniposide—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Zolmitriptan—Arrhythmia—Carmustine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Zolmitriptan—Leukopenia—Bleomycin—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Zolmitriptan—Cystitis—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Zolmitriptan—Cardiac disorder—Vincristine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Zolmitriptan—Body temperature increased—Fludarabine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Zolmitriptan—Vaginal infection—Methotrexate—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Zolmitriptan—Erythema—Carmustine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Zolmitriptan—Cough—Bleomycin—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Zolmitriptan—Angiopathy—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Zolmitriptan—Diarrhoea—Teniposide—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Zolmitriptan—Chest pain—Bleomycin—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Zolmitriptan—Myalgia—Bleomycin—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Zolmitriptan—Back pain—Carmustine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Zolmitriptan—Discomfort—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Zolmitriptan—Chills—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Zolmitriptan—Ecchymosis—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Zolmitriptan—Bladder pain—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Zolmitriptan—Urine output increased—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Zolmitriptan—Neoplasm—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Zolmitriptan—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Zolmitriptan—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Zolmitriptan—Confusional state—Bleomycin—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Zolmitriptan—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Zolmitriptan—Tremor—Carmustine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Zolmitriptan—Oedema—Bleomycin—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Zolmitriptan—Erythema—Mitoxantrone—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Zolmitriptan—Infection—Bleomycin—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Zolmitriptan—Back pain—Vincristine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Zolmitriptan—Vomiting—Teniposide—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Zolmitriptan—Agitation—Carmustine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Zolmitriptan—Asthenia—Fludarabine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Zolmitriptan—Rash—Teniposide—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Zolmitriptan—Dermatitis—Teniposide—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Zolmitriptan—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Zolmitriptan—Headache—Teniposide—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Zolmitriptan—Pruritus—Fludarabine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Zolmitriptan—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Zolmitriptan—Back pain—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Zolmitriptan—Leukopenia—Carmustine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Zolmitriptan—Anorexia—Bleomycin—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Zolmitriptan—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Zolmitriptan—Agitation—Vincristine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Zolmitriptan—Photosensitivity—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Zolmitriptan—Polyuria—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Zolmitriptan—Diarrhoea—Fludarabine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Zolmitriptan—Convulsion—Carmustine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Zolmitriptan—Hypertension—Carmustine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Zolmitriptan—Nausea—Teniposide—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Zolmitriptan—Vertigo—Vincristine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Zolmitriptan—Leukopenia—Vincristine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Zolmitriptan—Chest pain—Carmustine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Zolmitriptan—Myalgia—Carmustine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Zolmitriptan—Anxiety—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Zolmitriptan—Paraesthesia—Bleomycin—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Zolmitriptan—Malaise—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Zolmitriptan—Dyspnoea—Bleomycin—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Zolmitriptan—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Zolmitriptan—Convulsion—Vincristine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Zolmitriptan—Hypertension—Vincristine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Zolmitriptan—Confusional state—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Zolmitriptan—Oedema—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Zolmitriptan—Decreased appetite—Bleomycin—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Zolmitriptan—Myalgia—Vincristine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Zolmitriptan—Cough—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Zolmitriptan—Infection—Carmustine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Zolmitriptan—Vomiting—Fludarabine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Zolmitriptan—Convulsion—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Zolmitriptan—Rash—Fludarabine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Zolmitriptan—Dermatitis—Fludarabine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Zolmitriptan—Hypertension—Mitoxantrone—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Zolmitriptan—Pain—Bleomycin—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Zolmitriptan—Headache—Fludarabine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Zolmitriptan—Tachycardia—Carmustine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Zolmitriptan—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Zolmitriptan—Myalgia—Mitoxantrone—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Zolmitriptan—Chest pain—Mitoxantrone—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Zolmitriptan—Arthralgia—Mitoxantrone—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Zolmitriptan—Anxiety—Mitoxantrone—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Zolmitriptan—Discomfort—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Zolmitriptan—Oedema—Vincristine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Zolmitriptan—Anorexia—Carmustine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Zolmitriptan—Infection—Vincristine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Zolmitriptan—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Zolmitriptan—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Zolmitriptan—Confusional state—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Zolmitriptan—Nervous system disorder—Vincristine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Zolmitriptan—Oedema—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Zolmitriptan—Nausea—Fludarabine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Zolmitriptan—Infection—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Zolmitriptan—Shock—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Zolmitriptan—Urticaria—Bleomycin—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Zolmitriptan—Anorexia—Vincristine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Zolmitriptan—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Zolmitriptan—Body temperature increased—Bleomycin—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Zolmitriptan—Insomnia—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Zolmitriptan—Skin disorder—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Zolmitriptan—Irritability—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Zolmitriptan—Paraesthesia—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Zolmitriptan—Mood swings—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Zolmitriptan—Dyspnoea—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Zolmitriptan—Somnolence—Carmustine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Zolmitriptan—Anorexia—Mitoxantrone—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Zolmitriptan—Ataxia—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Zolmitriptan—Decreased appetite—Carmustine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Zolmitriptan—Insomnia—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Zolmitriptan—Paraesthesia—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Zolmitriptan—Pain—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Zolmitriptan—Constipation—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Zolmitriptan—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Zolmitriptan—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Zolmitriptan—Decreased appetite—Vincristine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Zolmitriptan—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Zolmitriptan—Somnolence—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Zolmitriptan—Feeling abnormal—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Zolmitriptan—Asthenia—Bleomycin—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Zolmitriptan—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Zolmitriptan—Pain—Vincristine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Zolmitriptan—Constipation—Vincristine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Zolmitriptan—Pruritus—Bleomycin—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Zolmitriptan—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Zolmitriptan—Eosinophilia—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Zolmitriptan—Pancreatitis—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Zolmitriptan—Pain—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Zolmitriptan—Constipation—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Zolmitriptan—Body temperature increased—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Zolmitriptan—Abdominal pain—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Zolmitriptan—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Zolmitriptan—Abdominal pain—Vincristine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Zolmitriptan—Body temperature increased—Vincristine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Zolmitriptan—Urticaria—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Zolmitriptan—Hypersensitivity—Carmustine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Zolmitriptan—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Zolmitriptan—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Zolmitriptan—Pneumonia—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Zolmitriptan—Vomiting—Bleomycin—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Zolmitriptan—Rash—Bleomycin—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Zolmitriptan—Dermatitis—Bleomycin—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Zolmitriptan—Asthenia—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Zolmitriptan—Stomatitis—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Zolmitriptan—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Zolmitriptan—Hypersensitivity—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Zolmitriptan—Sweating—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Zolmitriptan—Haematuria—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Zolmitriptan—Epistaxis—Methotrexate—lymphatic system cancer	0.00099	0.00099	CcSEcCtD
Zolmitriptan—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00099	0.00099	CcSEcCtD
Zolmitriptan—Asthenia—Vincristine—lymphatic system cancer	0.00099	0.00099	CcSEcCtD
Zolmitriptan—Diarrhoea—Carmustine—lymphatic system cancer	0.000989	0.000989	CcSEcCtD
Zolmitriptan—Nausea—Bleomycin—lymphatic system cancer	0.000983	0.000983	CcSEcCtD
Zolmitriptan—Asthenia—Mitoxantrone—lymphatic system cancer	0.000964	0.000964	CcSEcCtD
Zolmitriptan—Dizziness—Carmustine—lymphatic system cancer	0.000956	0.000956	CcSEcCtD
Zolmitriptan—Diarrhoea—Vincristine—lymphatic system cancer	0.000944	0.000944	CcSEcCtD
Zolmitriptan—Pharyngitis—Methotrexate—lymphatic system cancer	0.000935	0.000935	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00093	0.00093	CcSEcCtD
Zolmitriptan—Urethral disorder—Methotrexate—lymphatic system cancer	0.000923	0.000923	CcSEcCtD
Zolmitriptan—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000919	0.000919	CcSEcCtD
Zolmitriptan—Vomiting—Carmustine—lymphatic system cancer	0.000919	0.000919	CcSEcCtD
Zolmitriptan—Dizziness—Vincristine—lymphatic system cancer	0.000912	0.000912	CcSEcCtD
Zolmitriptan—Rash—Carmustine—lymphatic system cancer	0.000911	0.000911	CcSEcCtD
Zolmitriptan—Dermatitis—Carmustine—lymphatic system cancer	0.00091	0.00091	CcSEcCtD
Zolmitriptan—Headache—Carmustine—lymphatic system cancer	0.000905	0.000905	CcSEcCtD
Zolmitriptan—Tinnitus—Methotrexate—lymphatic system cancer	0.000878	0.000878	CcSEcCtD
Zolmitriptan—Vomiting—Vincristine—lymphatic system cancer	0.000877	0.000877	CcSEcCtD
Zolmitriptan—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000874	0.000874	CcSEcCtD
Zolmitriptan—Rash—Vincristine—lymphatic system cancer	0.00087	0.00087	CcSEcCtD
Zolmitriptan—Dermatitis—Vincristine—lymphatic system cancer	0.000869	0.000869	CcSEcCtD
Zolmitriptan—Headache—Vincristine—lymphatic system cancer	0.000864	0.000864	CcSEcCtD
Zolmitriptan—Nausea—Carmustine—lymphatic system cancer	0.000858	0.000858	CcSEcCtD
Zolmitriptan—Angiopathy—Methotrexate—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Zolmitriptan—Vomiting—Mitoxantrone—lymphatic system cancer	0.000854	0.000854	CcSEcCtD
Zolmitriptan—Immune system disorder—Methotrexate—lymphatic system cancer	0.000851	0.000851	CcSEcCtD
Zolmitriptan—Rash—Mitoxantrone—lymphatic system cancer	0.000847	0.000847	CcSEcCtD
Zolmitriptan—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000846	0.000846	CcSEcCtD
Zolmitriptan—Chills—Methotrexate—lymphatic system cancer	0.000845	0.000845	CcSEcCtD
Zolmitriptan—Headache—Mitoxantrone—lymphatic system cancer	0.000842	0.000842	CcSEcCtD
Zolmitriptan—Erythema—Methotrexate—lymphatic system cancer	0.00082	0.00082	CcSEcCtD
Zolmitriptan—Nausea—Vincristine—lymphatic system cancer	0.000819	0.000819	CcSEcCtD
Zolmitriptan—Dysgeusia—Methotrexate—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Zolmitriptan—Nausea—Mitoxantrone—lymphatic system cancer	0.000798	0.000798	CcSEcCtD
Zolmitriptan—Back pain—Methotrexate—lymphatic system cancer	0.000793	0.000793	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000761	0.000761	CcSEcCtD
Zolmitriptan—Malaise—Methotrexate—lymphatic system cancer	0.00074	0.00074	CcSEcCtD
Zolmitriptan—Vertigo—Methotrexate—lymphatic system cancer	0.000737	0.000737	CcSEcCtD
Zolmitriptan—Leukopenia—Methotrexate—lymphatic system cancer	0.000734	0.000734	CcSEcCtD
Zolmitriptan—Cough—Methotrexate—lymphatic system cancer	0.000716	0.000716	CcSEcCtD
Zolmitriptan—Convulsion—Methotrexate—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Zolmitriptan—Myalgia—Methotrexate—lymphatic system cancer	0.000698	0.000698	CcSEcCtD
Zolmitriptan—Chest pain—Methotrexate—lymphatic system cancer	0.000698	0.000698	CcSEcCtD
Zolmitriptan—Arthralgia—Methotrexate—lymphatic system cancer	0.000698	0.000698	CcSEcCtD
Zolmitriptan—Discomfort—Methotrexate—lymphatic system cancer	0.00069	0.00069	CcSEcCtD
Zolmitriptan—Confusional state—Methotrexate—lymphatic system cancer	0.000675	0.000675	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000669	0.000669	CcSEcCtD
Zolmitriptan—Infection—Methotrexate—lymphatic system cancer	0.000665	0.000665	CcSEcCtD
Zolmitriptan—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000656	0.000656	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000655	0.000655	CcSEcCtD
Zolmitriptan—Skin disorder—Methotrexate—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000647	0.000647	CcSEcCtD
Zolmitriptan—Anorexia—Methotrexate—lymphatic system cancer	0.000638	0.000638	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00061	0.00061	CcSEcCtD
Zolmitriptan—Insomnia—Methotrexate—lymphatic system cancer	0.000605	0.000605	CcSEcCtD
Zolmitriptan—Paraesthesia—Methotrexate—lymphatic system cancer	0.000601	0.000601	CcSEcCtD
Zolmitriptan—Dyspnoea—Methotrexate—lymphatic system cancer	0.000597	0.000597	CcSEcCtD
Zolmitriptan—Somnolence—Methotrexate—lymphatic system cancer	0.000595	0.000595	CcSEcCtD
Zolmitriptan—Dyspepsia—Methotrexate—lymphatic system cancer	0.000589	0.000589	CcSEcCtD
Zolmitriptan—Decreased appetite—Methotrexate—lymphatic system cancer	0.000582	0.000582	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000578	0.000578	CcSEcCtD
Zolmitriptan—Pain—Methotrexate—lymphatic system cancer	0.000572	0.000572	CcSEcCtD
Zolmitriptan—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000552	0.000552	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000547	0.000547	CcSEcCtD
Zolmitriptan—Urticaria—Methotrexate—lymphatic system cancer	0.000532	0.000532	CcSEcCtD
Zolmitriptan—Abdominal pain—Methotrexate—lymphatic system cancer	0.000529	0.000529	CcSEcCtD
Zolmitriptan—Body temperature increased—Methotrexate—lymphatic system cancer	0.000529	0.000529	CcSEcCtD
Zolmitriptan—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000493	0.000493	CcSEcCtD
Zolmitriptan—Asthenia—Methotrexate—lymphatic system cancer	0.00048	0.00048	CcSEcCtD
Zolmitriptan—Pruritus—Methotrexate—lymphatic system cancer	0.000474	0.000474	CcSEcCtD
Zolmitriptan—Diarrhoea—Methotrexate—lymphatic system cancer	0.000458	0.000458	CcSEcCtD
Zolmitriptan—Dizziness—Methotrexate—lymphatic system cancer	0.000443	0.000443	CcSEcCtD
Zolmitriptan—Vomiting—Methotrexate—lymphatic system cancer	0.000426	0.000426	CcSEcCtD
Zolmitriptan—Rash—Methotrexate—lymphatic system cancer	0.000422	0.000422	CcSEcCtD
Zolmitriptan—Dermatitis—Methotrexate—lymphatic system cancer	0.000422	0.000422	CcSEcCtD
Zolmitriptan—Headache—Methotrexate—lymphatic system cancer	0.000419	0.000419	CcSEcCtD
Zolmitriptan—Nausea—Methotrexate—lymphatic system cancer	0.000398	0.000398	CcSEcCtD
